Dec 23 (Reuters) - Sedana Medical AB (publ) SEDANA.ST :
* SEDANA MEDICAL RECEIVES POSITIVE OPINION FROM EMA'S
PEDIATRIC
COMMITTEE ON REDUCED PEDIATRIC STUDY DESIGN
* CHANGE WILL ENABLE FASTER STUDY COMPLETION, EARLIER
APPROVAL OF
PEDIATRIC INDICATION AND REDUCED INVESTMENTS
* EXPECTS TO CONCLUDE STUDY BASED ON APPROXIMATELY 90
PATIENTS,
INSTEAD OF 160 PATIENTS PREVIOUSLY.
* NOW EXPECTS EUROPEAN APPROVAL OF PEDIATRIC INDICATION IN A
DECENTRALIZED PROCEDURE IN Q4 2023 OR Q1 2024
Source text for Eikon: ID:nWkr3lwVP2
Further company coverage: SEDANA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))